Should patients with cerebral amyloid angiopathy have any statin medications discontinued?

There is equipoise about use or discontinuation of statin in patients who have had an intraparenchymal hemorrhage attributed cerebral amyloid angiopathy. A multicenter clinical trial is investigating this question (https://clinicaltrials.gov/ct2/show/NCT03936361). I would base continuing vs discontinuing a statin on a patient's overall vascular risk, using clinical diagnoses and/or the ASCVD score to help guide your decision.